Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease

Better Therapeutics, Inc. , a pioneer in developing prescription digital therapeutics to treat cardiometabolic diseases, today announced it has submitted a request to the U.S. Food and Drug...

Related Keywords

Arizona ,United States ,American ,Frank Karbe ,Naim Alkhouri ,Company Livvita Liver Study ,Exchange Commission ,Drug Administration ,Fatty Liver Program At Arizona Health ,Nasdaq ,Better Therapeutics Inc ,Better Therapeutics ,Breakthrough Device Designation ,Livvita Liver Study ,Gastro Hep ,Better Therapeutic ,Fatty Liver Program ,Arizona Liver Health ,Principal Investigator ,Device Designation ,Markets ,